Amit Tiwari, Ph.D., Inducted into AIMBE College of Fellows
| The American Institute for Medical and Biological Engineering (AIMBE) recently inducted Amit Tiwari, Ph.D., associate dean of research and graduate studies for the University of Arkansas for Medical Sciences (UAMS) College of Pharmacy, into its prestigious College of Fellows.
Tiwari was inducted as an AIMBE Fellow on April 13 in Arlington, Virginia.
Tiwari was nominated, reviewed and elected by peers and members of the College of Fellows for distinguished contributions to overcoming cancer drug resistance with pioneering biomedical technologies and advancing workforce diversity through international STEM partnerships, the institute said in a news release. An induction ceremony was held April 13 in Arlington, Virginia.
“I am deeply honored to be elected as an AIMBE Fellow,” Tiwari said. “To be included among such an accomplished group is both humbling and energizing, and I am especially grateful to the mentors who guided me and the mentees who continue to challenge and inspire me. This recognition reflects their impact as much as my own work.
“Being elected to the AIMBE College of Fellows strengthens my commitment to advancing biomedical and pharmaceutical engineering through meaningful research, strong public advocacy, and building collaborative programs, while continuing to build and support the next generation of learners across the globe who will shape the future of our field,” he added.
Election to the AIMBE College of Fellows is among the highest professional distinctions accorded to medical and biological engineers, comprised of the top 2% of engineers in these fields. It honors those who have made outstanding contributions to engineering and medicine research, practice, or education. Fellows represent more than 35 countries and include multiple Nobel Prize laureates and recipients of National Medals for science, technology and innovation.
Tiwari is a well-known cancer researcher and expert in the areas of drug resistance, drug discovery, and cell death mechanisms. He has authored more than 220 peer-reviewed journal articles, as well as 19 book chapters. His work has been cited more than 10,000 times, influencing FDA guidance on combination therapies. He holds four U.S. patents in cancer therapeutics, with several pending applications. Over the last decade, his research has been funded by the NIH National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Cancer Institute, National Institutes of Health, United States Department of Defense, National Science Foundation, among others. Over his career, he has received more than $10 million in extramural funding.
Tiwari has received multiple awards over his career for his role as an educator, mentor and scientist. He served as editor-in-chief of the international, peer-reviewed, open-source Cancer Reports journal and is an editor or associate editor for six more. He is on editorial board of Drug Resistance Updates and Journal of Clinical Medicine, among several others.
Tiwari received his bachelor’s degree from RamEesh Institute of Vocational and Technical Education in Greater Noida, India, and his master’s and doctoral degrees in pharmaceutical sciences from St. John’s University in New York. He received postdoctoral training at the Icahn School of Medicine at Mount Sinai in New York.